u/RedPlumpTomato

3 theses · first seen Sep 4, 2026

Window	Theses	Resolved	Wins	Win rate	Avg return	Median return
1d	3	3	1	33%	-4.5%	-5.0%
3d	3	3	1	33%	-13.1%	-6.8%
1w	3	3	2	67%	-28.9%	-22.4%
1m	3	3	1	33%	-15.2%	-18.6%
3m	3	3	1	33%	+289.7%	-54.7%
6m	0	0	0	—	—	—
1y	0	0	0	—	—	—

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$BURUr/pennystocksStock Infobearish

u/RedPlumpTomato · 103d ago2 prior · 33% at 3mo

My AI Slop Analysis: BURU (since y'all can't shut up about this)

Nuburu is a delisted penny stock with negative TTM revenue, 700M fully diluted shares post-financing, sub-nine-month runway, and an unresolved Italian regulatory approval for its Tekne acquisition. Insiders are uncashed and well-compensated despite 98.8% share decline; the stock is a binary lottery ticket facing active delisting proceedings with no independent fundamental support.

At post $0.04Now $0.25+501.2% since postedas of Nov 2, 4:15 PM ET

1d+18.1%

3d+7.0%

1w-12.0%

1m+2.2%

3m+995.2%

6m—

1y—

original post →

$GNTAr/pennystocksGeneral Discussionbullish

u/RedPlumpTomato · 118d ago2 prior · 33% at 3mo

“15 minutes of homework, not a chase; confirm SAEN name change and defense pivot before deciding”

My AI Slop Analysis #1

GNTA trades at 1.85x net cash ($20.5M) with a real $20.5M balance-sheet cushion and a Feb 2026 pivot to Italian defense business as part of macro consolidation. At $1.61 (6.2x below $10 52-week high), it's a beaten-down name with optionality, not yet discovered by the sub, making it speculative but not a zero if the SAEN name change and defense pivot are confirmed.

At post $1.61Now $0.82-49.3% since postedas of Nov 2, 4:15 PM ET

1d-5.0%

3d-6.8%

1w-22.4%

1m-18.6%

3m-54.7%

6m—

1y—

original post →

$CLROr/pennystocksGeneral Discussionbearish

u/RedPlumpTomato · 118d ago2 prior · 33% at 3mo

“watchlist only; if fails retest and pulls back into $5–7 base, that's a second-chance setup”

My AI Slop Analysis #1

CLRO spiked 4.3x in four sessions on brain-implant pivot hype, but with only $756k cash, $7.5M annual burn, and ~5 weeks of runway, the company will issue dilutive paper into this rally. Current holders will need to dump on fresh buyers at $13.84 (near 52-week high of $16.50), making this a trap for chasers.

At post $13.84Now $5.65-59.2% since postedas of Nov 2, 4:15 PM ET

1d-26.6%

3d-39.4%

1w-52.2%

1m-29.2%

3m-71.5%

6m—

1y—

original post →

End of results.